Inappropriate sinus tachycardia medical therapy

Revision as of 15:23, 26 February 2013 by Prashanthsaddala (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Inappropriate sinus tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Inappropriate Sinus Tachycardia from other Medical Conditions

Epidemiology and Demographics

Diagnosis

Diagnostic Criteria

History and Symptoms

Electrocardiogram

Treatment

ACC/AHA/ESC Treatment Guidelines

Medical Therapy

Surgery

Case Studies

Case #1

Inappropriate sinus tachycardia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Inappropriate sinus tachycardia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Inappropriate sinus tachycardia medical therapy

CDC on Inappropriate sinus tachycardia medical therapy

Inappropriate sinus tachycardia medical therapy in the news

Blogs on Inappropriate sinus tachycardia medical therapy

Directions to Hospitals Treating Inappropriate sinus tachycardia

Risk calculators and risk factors for Inappropriate sinus tachycardia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

Pharmacotherapy

Treatments in the form of pharmacological therapy or catheter ablation are available, although it is currently difficult to treat successfully.

Beta Blockers

In so far as the pathophysiology of IST involves abnormal sensitivity to adrenaline, betaa-blockers can be helpful.

Calcium Channel Blockers

Although calcium channel blockers slow conduction through the AV node, they have been marginally effective in the treatment of IST.

Ivabradine

A new selective sinus node inhibitor Ivabradine is also being used to treat IST.

Treatments Related to Dysautonomia and POTS

In so far as the underlying pathophysiology may involve a dysautonomia and features of Postural orthostatic tachycardia syndrome (POTS), some therapies more commonly used to treat these disorders have been tried:

POTS and dysautonomia have been associated with decreases in blood volume, and this drug promotes sodium retention.

Midodrine increases vasoconstriction, and prevents falls in blood pressure.

SSRIs have proven effective in treating some patients with dysautonomia.

References


Template:WikiDoc Sources